Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effects of Milk Fat Globule Membrane (MFGM) - Enriched Formula With Reduced Energy and Protein Content on Growth and Development (TUMME)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Niklas Timby, Umeå University Identifier:
First received: February 15, 2008
Last updated: October 28, 2016
Last verified: October 2016

Formula-fed infants differ from breast-fed infants in the growth pattern, risk for obesity and cardiovascular diseases, neurological development and morbidity in infections.

The investigators' hypothesis is that a modified formula with reduced energy and protein content and enrichment with Milk Fat Globule Membrane (MFGM) containing bioactive proteins and phospholipids will reduce the difference between formula-fed and breast-fed infants.

Condition Intervention
Dietary Supplement: Modified formula (MFGM-enriched formula with reduced energy and protein content)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Double-blinded Interventional Study on the Effects of MFGM-enriched Formula With Reduced Energy and Protein Content on Growth and Development

Further study details as provided by Umeå University:

Primary Outcome Measures:
  • Body composition [ Time Frame: 4 months ]

Secondary Outcome Measures:
  • Neurological development [ Time Frame: 1 year ]

Estimated Enrollment: 240
Study Start Date: March 2008
Estimated Study Completion Date: March 2018
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Modified formula
Dietary Supplement: Modified formula (MFGM-enriched formula with reduced energy and protein content)
MFGM-enriched formula with reduced energy and protein content
No Intervention: 2
Standard formula
No Intervention: 3


Ages Eligible for Study:   up to 2 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Term infants with birth weight 2500-4500 gr
  • Fed with breastmilk only or formula only before 2 months of age

Exclusion Criteria:

  • Chronic illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00624689

Dept of clinical sciences, pediatrics, Umeå University
Umeå, Sweden, SE-90185
Sponsors and Collaborators
Umeå University
  More Information

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Niklas Timby, M.D, Researcher, Umeå University Identifier: NCT00624689     History of Changes
Other Study ID Numbers: TUMME
Study First Received: February 15, 2008
Last Updated: October 28, 2016

Keywords provided by Umeå University:
Body composition
Glucose tolerance
Intima-media thickness
Visual acuity
Neurological development processed this record on April 26, 2017